Evaluation of hypotheses regarding mechanisms of action of growth promotants and repartitioning agents using a simulation model of lamb metabolism and growth

Development of a dynamic, mechanistic model of lamb metabolism and growth

A dynamic, mechanistic model of lamb metabolism and growth was developed for the purpose of evaluating hypotheses regarding the mechanisms of action of growth promotants. The model relates tissue growth to DNA accretion and protein turn-over. State variables include circulating amino acids, glucose, lipids and acetate; four protein pools (carcass, viscera, other tissues and wool) and storage triacylglycerol are also included. Equations are mainly of the Michaelis-Menten form, allowing for nutrient utilization patterns to be determined by relative tissue affinities for substrates (ko.5), enzymatic capacities (Vmax) and substrate concentrations ([S]). Protein degradation rates are defined as first-order with respect to protein. The model adequately simulated growth from 20 to 40 kg empty body weight. Simulated changes in nutrient input yielded reasonable energy balance response patterns, although theoretical growth efficiencies were greater than those observed in practice. Variations in volatile fatty acid absorption patterns were accommodated well, with predicted nitrogen retention closely approximating experimental observations. The model also responded appropriately to changes in dietary protein level, with body fat varying inversely with amino acid absorption. In summary, the model was found to perform adequately for the purpose of examining mechanisms responsible for alteration of growth and body composition.

Beta-adrenergic agonists and hypertrophy of skeletal muscles

Chronic administration of some beta-adrenergic agonists markedly stimulates hypertrophy of skeletal muscles. It appears that type II fibers are more responsive to beta-adrenergic agonists than type I fibers. The hypertrophic effect of beta-adrenergic agonists is transient, with the effect diminishing during prolonged treatment. Similarly, some cellular responses including the increase in RNA concentration and the decrease in calpain I activity are also short-lived. Recent evidence suggests that the temporal response is associated with decreased beta-adrenoceptor density. Both increased rate of protein synthesis and/or decreased protein degradation have been suggested as the mechanism of action of these compounds on hypertrophy of skeletal muscles. It is important to consider the temporal nature of cellular responses to chronic treatment of beta-adrenergic agonists as well as the differential effects of these compounds on protein metabolism among skeletal muscle fiber types when investigating the mechanism(s) of action of these compounds.